Skip to main content

Advertisement

SpringerLink
Log in

Clinical trials in systemic lupus erythematosus

  • Clinical Trials Review
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Liang MH, Fortin PR: Viewpoint: response criteria for clinical trials in systemic lupus erythematosus. Lupus 1995, 4:336–338.

    Article  PubMed  CAS  Google Scholar 

  2. Suzuki N, Suzuki T, Sakane T: Hormones and lupus: defective dehydroepiandrosterone activity induces impaired interleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosus. Ann Med Intern 1996, 147:248–252.

    CAS  Google Scholar 

  3. van Vollenhoven RF, Morabito LM, Engleman EG, McGuire JL:Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. J Rheumatol 1998, 25:285–289.

    PubMed  Google Scholar 

  4. Petri M, Lahita R, McGuire J, et al.: Results of the GL701 (DHEA) multicenter steroid-sparing SLE study [abstract]. Arthritis Rheum 1997, 40(suppl):S327.

    Article  Google Scholar 

  5. van Vollenhoven RF, Park JL, Genovese MC, et al.: A doubleblind, placebo-controlled clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus 1999, 8:169–170.

    Article  Google Scholar 

  6. Walker SE, McMurray RW, Houri JM, et al.: Effects of prolactin in stimulating disease activity in systemic lupus erythematosus. Ann NY Acad Sci 1998, 840:762–772.

    Article  PubMed  CAS  Google Scholar 

  7. Buskila D, Lorber M, Neumann L, et al.: No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996, 23:629–632.

    PubMed  CAS  Google Scholar 

  8. Jimena P, Aguirre MA, Lopez-Curbelo A, et al.: Prolactin levels in patients with systemic lupus erythematosus: a case controlled study. Lupus 1998, 7:383–386.

    Article  PubMed  CAS  Google Scholar 

  9. Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, et al.: Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus 1998, 7:414–419.

    Article  PubMed  CAS  Google Scholar 

  10. Kim MY, Buyon JP, Petri M, et al.: Equivalence trials in SLE research: issues to consider. Lupus 1999, 8:620–626.

    Article  PubMed  CAS  Google Scholar 

  11. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic antibody production. J Clin Invest 1996,97:2063–2073.

    Article  PubMed  CAS  Google Scholar 

  12. Koshy M, Berger D, Crow MK: Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 1996, 98:826–837.

    Article  PubMed  CAS  Google Scholar 

  13. Mohan C, Shi Y, Laman JD, Datta SK: Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 1995, 154:1470–1480.

    PubMed  CAS  Google Scholar 

  14. Carneiro JR, Sato EI: Double blind, randomized, placebo controlled trial of methotrexate in systemic lupus erythematosus. J Rheumatol 1999, 26:1275–1279.

    PubMed  CAS  Google Scholar 

  15. Ferland D, Fortin PR: Recruitment strategies in superiority trials in SLE: lessons from the study of methotrexate in lupus erythematosus (SMILE). Lupus 1999, 8:606–611.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Hospital for Joint Diseases, New York University School of Medicine, 301 East 17th Street, 10003, New York, NY, USA

    Jill P. Buyon MD

Authors
  1. Jill P. Buyon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buyon, J.P. Clinical trials in systemic lupus erythematosus. Curr Rheumatol Rep 2, 11–12 (2000). https://doi.org/10.1007/s11926-996-0062-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-996-0062-y

Keywords

Search

Navigation